China Arthroscopy Market Size, Share & Trends Analysis Report By Product (Ablation Systems, Visualization Systems, Fluid Management Systems), By Application (Knee, Shoulder, Hip, Elbow), And Segment Forecasts, 2025 - 2030

China Arthroscopy Market Size, Share & Trends Analysis Report By Product (Ablation Systems, Visualization Systems, Fluid Management Systems), By Application (Knee, Shoulder, Hip, Elbow), And Segment Forecasts, 2025 - 2030

Cardiovascular Devices Market Growth & Trends

The global cardiovascular devices market size is anticipated to reach USD 86.36 billion by 2030 and is anticipated to expand at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is significantly influenced by the increasing prevalence of cardiovascular diseases (CVDs) globally. As lifestyle changes and aging populations contribute to higher rates of conditions such as hypertension, heart attacks, and strokes, there is a growing demand for advanced medical technologies. Technological advancements in device design and functionality have led to improved patient outcomes, further driving market growth. The integration of minimally invasive techniques has also gained traction, appealing to both healthcare providers and patients seeking less traumatic treatment options.

Cardiovascular Disease (CVD) ranks among the top medical conditions globally. In May 2024, the CDC reported nearly 702,880 fatalities resulting from heart disease, representing 1 in every 5 deaths. Key factors propelling this market include rapid technological advancements, increased awareness & screening programs, and growth in demand for minimally invasive procedures.

Moreover, supportive government initiatives and funding aimed at enhancing healthcare infrastructure are propelling the market forward. Increased awareness regarding heart health among the general population has resulted in more individuals seeking preventive care and treatment options. Furthermore, the rise in healthcare expenditure across various regions is facilitating access to innovative cardiovascular devices, thereby expanding their adoption in clinical settings. In April 2024, MicroPort CRM introduced its new line of Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)-ENERGYA and TALENTIA-in Europe. These devices feature Bluetooth connectivity.

Cardiovascular Devices Market Report Highlights

• Based on product, surgical devices segment held largest revenue share of 68.8% in 2024 by product and is expected to grow at the highest CAGR over the forecast period due to their critical role in the cardiovascular device market, encompassing a wide range of products designed to diagnose, treat, and manage heart-related conditions.
• The diagnostic & monitoring segment is expected to grow at the fastest CAGR over the forecast period owing to technological advancements, such as miniaturization and integration of AI in diagnostic tools, which can improve accuracy & patient outcomes.
• Based on region, North America dominated the segment by region with a market share of 47.7% in 2024 due to an advanced healthcare infrastructure, high prevalence of CVDs, and significant R&D investments by regional players.
• Asia Pacific segment is expected to grow at the fastest CAGR over the forecast period owing to rising healthcare expenditures and government initiatives to improve healthcare infrastructure

Please note The report will be delivered in 2-3 business days upon order notification.